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Supplementary Methods: 
ICU population, nutrition and ICU care 
The cohort comprised all admissions from February 1st, 2012 to May 1st, 2016. We considered all 
trauma admissions to the emergency department (ED) of the Royal London Hospital that were 
admitted either directly to the adult ICU or via the operating theatre. All trauma patients are fed 
enterally as soon as possible, unless contraindicated. This follows the ESPEN guidelines in terms of 
calories delivered, feed constitution and the use of pro-kinetic drugs. Patients’ nutritional 
requirements are reviewed daily by the medical team, as well as the nutrition team and supplemented 
or replaced with parental nutrition where the enteral route is not wholly adequate or contraindicated. 
Blood sugars are maintained between 5-10 mmol/l using insulin sliding scales as necessary. 
Mechanically ventilated patients have sedation holds daily where applicable with aim to extubation 
or ventilator wean as soon as possible. Patients are encouraged to mobilise as soon as possible and 
are seen daily by physiotherapists. Individual patient data on nutritional intake was not available in 
this study. 
 
Secondary analyses 
To assess further the relationship between duration of ICU admission and blood test trajectories we 
stratified patients into 4 groups based on ICU length of stay (LoS) – 1-4 days, 5-9 days, 10-19 days and 
≥20 days. To assess any influence of AKI on renal parameters we plotted trajectories of urea, serum 
creatinine and urea:creatinine stratified by peak AKI stage and need for RRT. As AKI is strongly 
associated with risk of death, in this analysis we included all patients including early deaths. Baseline 
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serum creatinine for the acute trauma population was defined as the first documented in hospital. 
We used the KDIGO creatinine guidelines to define AKI.  
 
Statistical analysis  
Statistical analysis was performed in R v3.4.4 (R Foundation for Statistical Computing, Vienna, Austria) 
using RStudio v1.0.136 (RStudio Inc, Boston, MA, USA).  Continuous data are presented median with 
interquartile range (IQR) or range and were compared using the Wilcoxon rank sum test. Categorical 
data were compared using the Fisher’s test or Chi squared tests. Comparisons between multiple 
groups were made using the Kruskal-Wallis test. Trajectories of daily blood test results are displayed 
as rolling medians with 95% confidence-intervals of the point estimate of the median value which 
were determined using constrained B-Splines Nonparametric Regression Quantiles - using quadratic 
splines with curves constrained to pass through the median admission value (COBS, R package version 
1.3-3 https://CRAN.R-project.org/package=cobs). For discrimination of persistent need for intensive 
care logistic regression models were derived on each day using all blood test variables, with backward 
selection based on the minimisation of the Akaike information criterion (AIC) derived from the pooled 
residual chi-square. We then selected those variables retained after selection on at least 50% of days 
from day 10 to 25 and computed final daily logistic regression models for persistent need for intensive 
care based on these variables and compared with models based on baseline illness severity and 
antecedent demographics. Logistic regression receiver-operative characteristic curve areas under the 
curve (ROC-AUC) were calculated with 95% confidence intervals using DeLong's variance estimate 
with comparison using DeLong’s test. Linear regression for changes in muscle cross-sectional area over 
time was performed using ordinal least squares and the coefficient of determination (R2) was 
determined from the Pearson correlation coefficient, slopes were compared by inclusion of group 
allocation as a dummy variable in multiple linear regression including all patients with change in 
muscle area as the dependent variable and assessing the significance of an interaction term between 
group allocation and time in hospital. 
 
Biochemical signature of persistent critical illness 
We adapted the methodology reported by Iwashyna et al [1] to calculate the timing of persistent 
critical illness in the trauma population. We developed a simple prediction model of hospital mortality 
in patients on each day up to day 21 based on either, i) acute risk factors (New Injury Severity Score; 
documenting severity of traumatic injury, and APACHE 2 score without age; indicating extent of 
physiological instability) or ii) antecedent patient characteristics (age and Charlson Comorbidity 
Index).  After confirmation of the persistent critical illness timeframe, we used similar methodology 
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to understand the associations of persistent critical illness with data from routine bloods. Our primary 
outcome was persistent need for intensive care. We assessed ability of data from routine blood tests 
measured on each day of hospitalisation to discriminate persistent need for intensive care and 
compared this to models derived from a combination of both antecedent patient characteristics and 
initial illness severity.   
 
We adapted the analytic approach of both Iwashnyna et al [1] and Bagshaw et al [2]. First, we built a 
predictive logistic regression model of in-hospital mortality based on antecedent and acute illness 
characteristics at ICU admission. Second, we measured predictive abilities of the antecedent 
characteristics and acute illness component for patients alive and in the ICU on each day up to day 21. 
Lastly, to confirm the persistent critical illness timeframe, differences in c-statistics were used to 
compare the strength of the association between the acute and antecedent risk scores to in-hospital 
mortality. 
 
This analysis was based on hypotheses generated from work presented at the ESICM LIVES 2017 (0488 
Differential time course of creatinine and urea after major trauma and their association with duration 
of hospitalisation, Intensive Care Medicine Experimental 2017, 5(Suppl 2):0488, doi:  
https://doi.org/10.1186/s40635-017-0151-4) [3]. 
 
Computed Tomography image acquisition and analysis 
CT scan images were retrieved from the local picture archiving and communication system (PACS) and 
selected slices were retrieved for analysis as anonymized DICOM image files. Then, after manual 
exclusion of the intra-abdominal contents the total muscle CSA of the abdominal wall at the L3 level 
was defined using tissue specific attenuation of skeletal muscle (-29 to +150 Hounsfield Units).  Prior 
to analysis images were reviewed and rejected if major confounders of assessment were present –
major CT artefact due to metallic implants (i.e. spinal fixation) or anatomical disruption of the 
abdominal wall (laparostomy). Using the level of the vertebral vein as a landmark, a region of interest 
was manually defined around the psoas muscle.  
 
CT slices were analysed in random order and independent investigators performed the abdominal L3 
and L4 psoas assessments. Representative images of L4 psoas were reviewed by a senior radiologist 
and serial replicates of L3 analysis were performed to assess consistency of assessment.  In both 
methods muscle areas were normalised to patient size by dividing the area in centimetres squared 
(cm2) by the square of the patient’s height in metres (m).  We employed  predefined cut offs for 
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sarcopenia as  L3 muscle CSA of less than 55.4 cm2/m2 for males and 38.9 cm2/m2 for females [4]. We 
used ImageJ image-processing software [5]. Patients were divided into two groups; those with 
evolving, current or recent persistent critical illness at time of second CT (defined as patients with ICU 
length of stays of ≥10 days, or death in ICU before day 10, who had second CT either in ICU or within 
7 days of ICU discharge) and those who did not develop or had resolved persistent critical illness at 
time of second CT (defined as patients who were alive and out of ICU at day 10 or patients who had 
their 2nd CT at least 7 days after ICU discharge).  We assessed for correlation between muscle loss and 
time of second scan from admission using linear regression as described above and similarly assessed 
relationship between urea:creatinine and muscle area at time or first and second CT scans. This 
analysis was based on preliminary work presented at the 37th ISICEM 2017 (P459 Assessment of 
skeletal muscle wasting in critically ill trauma patients using serial computed tomography imaging, 
https://doi.org/10.1186/s13054-017-1629-x.)   
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Table S1: Logistic regression models were developed to discriminate persistent need for intensive care 
in all patients remaining in hospital with blood tests that day. Backward selection was based on the 
pooled residual chi-square of the model and minimization of the Akaike's information criterion.  
Variables considered were urea, creatinine, urea:creatinine (UCR), albumin, haemoglobin, CRP, 
neutrophil count, lymphocyte count, urea:creatinine appeared in 18/24 (13/16 from day 10 onward) 
models and Haemoglobin in 9/24 (8/16 from day 10).  Accordingly, we then constructed daily logistic 
models based on urea:creatinine and haemoglobin (the two best discriminating variables) to 
discriminate persistent need for intensive care daily and compared these to admission illness severity 
and age (see Fig S6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAY  VARIABLES RETAINED IN LOGISTIC MODEL 
AFTER BACKWARD SELECTION 
2 Albumin 
3 Albumin 
4 Albumin 
5 UCR, Albumin 
6 UCR, CRP 
7 UCR, Albumin 
8 UCR, Albumin, Lymphocytes 
9 UCR, CRP, Haemoglobin 
10 UCR, Albumin, Lymphocytes, Neutrophils 
11 Urea, Creatinine, Haemoglobin 
12 UCR, Haemoglobin 
13 UCR, Haemoglobin 
14 UCR, Lymphocytes 
15 UCR 
16 UCR, Haemoglobin 
17 Haemoglobin 
18 UCR 
19 UCR, Haemoglobin 
20 UCR, Haemoglobin 
21 UCR 
22 UCR 
23 UCR 
24 UCR, Haemoglobin 
25 None 
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Table S2. Patient characteristics showing comparisons between the whole ICU trauma cohort and those with two or more abdominal CT scans analysed. 
Medians and interquartile ranges or proportions. Wilcoxon Rank Sum test, Fisher exact test of Chi Squared test were used for continuous, dichotomous, or 
multiple category dichotomous data respectively. 
ISS - Injury severity score, NISS - new injury severity score, ICU - Intensive care unit, AKI - acute kidney injury, APACHE II - acute physiology and chronic 
health evaluation II, SAPS - simplified acute physiology score, KDIGO - kidney disease improving global outcomes.  
 
Patient characteristics Trauma cohort (excluding muscle assessment) Muscle assessment cohort p-value 
 
1269 107 
 
Age - years (median [IQR]) 43.00 [28.00, 58.00] 37.00 [23.00, 53.00] 0.025 
Sex = Male (%) 1009 (79.5) 89 (83.2) 0.434 
ISS (median [IQR]) 25.00 [16.00, 33.00] 32.00 [22.00, 43.00] <0.001 
NISS (median [IQR]) 34.00 [22.00, 50.00] 41.00 [28.00, 50.00] 0.004 
Charlson Comorbidity Index (%) 
  
0.240 
0 961 (75.7) 69 (64.5)  
1 186 (14.7) 23 (21.5)  
³2 123 (9.7) 15 (14.0)  
Hospital length of stay - days (median 
[IQR]) 
16.00 [7.00, 33.00] 39.00 [19.00, 65.50] <0.001 
ICU length of stay - days (median [IQR]) 5.14 [2.12, 11.40] 11.33 [5.54, 25.14] <0.001 
Albumin - g/L (median [IQR]) 38.00 [34.00, 42.00] 35.00 [30.50, 40.00] <0.001 
Urea - mmol/L (median [IQR]) 4.80 [3.80, 6.30] 5.40 [4.35, 6.85] 0.004 
Haemoglobin - g/dl (median [IQR]) 13.50 [12.70, 14.50] 14.10 [12.90, 14.80] 0.027 
Hospital admission creatinine - µmol/L 
(median [IQR]) 
82.00 [66.00, 102.00] 100.00 [86.00, 123.50] <0.001 
Hospital discharge creatinine - µmol/L 
(median [IQR]) 
62.00 [49.00, 76.00] 
 
56.00 [41.50, 71.50] 
 
0.004 
Time of last creatinine from admission - 
days (median [IQR]) 
11.70 [3.89, 27.64] 
 
33.54 [17.61, 60.65] 
 
<0.001 
Renal replacement therapy (%) 46 (3.6) 18 (16.8) <0.001 
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AKI KDIGO stage (%) 
  
<0.001 
0 1062 (83.7) 59 (55.1)  
1 132 (10.4) 28 (26.2)  
2 16 (1.3) 1 (0.9)  
3 59 (4.6) 19 (17.8)  
Hospital mortality (%) 239 (18.8) 12 (11.2) 0.067 
Site of Injury (%)    
Brain injury 661 (52.1) 23 (21.5) <0.001 
Isolated brain injury 395 (31.1) 13 (12.1) <0.001 
Abdomen 128 (10.1) 42 (39.3) <0.001 
Chest 388 (30.6) 46 (43.0) 0.011 
Pelvis 103 (8.1) 30 (28.0) <0.001 
Limbs 119 (9.4) 13 (12.1) 0.446 
Face and/or Neck 93 (7.3) 6 (5.6) 0.638 
Other 64 (5.1) 5 (4.7) 1 
Spine 142 (11.2) 14 (13.1) 0.664 
APACHE II (median [IQR]) 11.00 [8.00, 16.00] 11.00 [8.00, 15.00] 0.960 
SAPS II (median [IQR]) 35.00 [28.00, 43.00] 33.50 [28.00, 43.00] 0.627 
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Table S3: Comparison of CT-scan muscle cross-sectional area, serum urea and creatinine between admission (scan 1) and second inpatient scan (scan2). 
Patients categorized into groups as follows i) patients developing persistent critical illness re-scanned before day 10 (including early deaths in ICU), ii) 
patients who did not develop persistent critical illness re-scanned before day 10, iii) patients with persistent critical illness re-scanned in ICU from day 10 or 
within 1 week of ICU discharge, iv) patients scanned from day 10 who either did not have persistent critical illness or who were rescanned at least 1 week 
after ICU discharge. Continuous parameters are presented as median [Inter quartile range] and categorical parameters are presented as n (%).  . 
Comparisons using Wilcoxon signed rank test for paired continuous data or Fisher’s test for categorical data.  LoS Length of Stay, IQR interquartile range, 
CSA cross-sectional area 
 
Time between 
scans: 
 Scanned 1-9 days  Scanned on or after day 10 
i) Died or in ICU day 10 
N=28, 
Scan 2 median day 6 [5, 8], 
Median ICU LoS 15 [11,26] 
ii) Discharged ICU and alive d10 
N=31, 
Scan 2 median day 4 [1,7],  
Median ICU LoS 5 [3,8] 
iii) ICU LoS >10d, Scan 2 in ICU or 
within 7 days of ICU discharge 
N=25,  
Scan 2 Median day 16 [13, 23],  
Median ICU LoS 26 [17,36] 
iv) ICU LoS ≥10d or scanned >7 days 
after ICU discharge 
N=23,  
Scan 2 median day 44 [28, 59], 
 Median ICU LoS 13 [7,25]  
Admission Scan 2 p Admission Scan 2 p Admission Scan 2 p Admission Scan 2 p 
L4 Psoas CSA cm2 
median [IQR] 
32.7  
[28.5, 38.0] 
31.1  
[22.7, 36.4] 
<0.001 
31.1  
[22.7, 26.4] 
27.6  
[22.6, 33.9] 
0.016 
34.6  
[25.2, 41.2] 
23.0  
[13.2, 
29.6]  
<0.001 
30.0  
[27.5, 37,7] 
21.6  
[15.7, 
26.3] 
<0.001 
L4 Psoas index 
cm2/m2  
median [IQR] 
10.8  
[9.6,11.9] 
10.3  
[8.5, 11.3] 
<0.001 
9.9  
[7.5, 11.6] 
9.3  
[7.5, 10.6] 
0.016 
10.7  
[8.5, 13.0] 
7.1  
[4.9, 10.3] 
<0.001 
9.9  
[8.4, 11.6] 
6.8  
[5.5, 8.5] 
<0.001 
L3 CSA cm2 
median [IQR] 
185  
[175, 209] 
187  
[159, 207] 
0.080 
176  
[145, 183] 
167  
[134, 183] 
0.200 
174  
[149, 202] 
138  
[100, 176] 
<0.001 
174  
[157, 197] 
140  
[119, 151] 
<0.001 
L3 Muscle index 
cm2/m2  
median [IQR] 
61  
[55, 71] 
60  
[53, 64] 
0.113 
56  
[49, 68] 
54  
[50, 60] 
0.210 
56  
[49, 68] 
41  
[36, 55] 
<0.001 
56  
[50, 62] 
44  
[40, 49] 
<0.001 
Sarcopenia 
 n (%) 
2/24  
(8%) 
4/24  
(16%) 
0.666 9/25 (36%) 
12/25  
(48%) 
0.017 7/19 (36%) 
14/19 
(74%) 
0.049 6/22 (27%) 
19/21 
(86%) 
<0.001 
Creatinine  
Median - µmol/L 
[IQR] 
106  
[91, 124] 
76  
[50, 150] 
0.355 
96  
[74, 110] 
63  
[53, 88] 
0.002 
103  
[83, 129] 
64  
[45, 80] 
0.002 
107  
[89, 142] 
62  
[44, 73] 
<0.001 
Urea  
Median - mmol/L 
[IQR] 
5.4  
[4.3, 6.4] 
7.0  
[5.2, 11.3] 
<0.001 
5.2  
[4.0, 6.6] 
5.2  
[4.3, 8.0] 
0.472 
5.6  
[4.1, 6.8] 
9.1  
[6.7, 14.8] 
<0.001 
5.7  
[4.7, 7.0] 
4.1  
[3.1, 6.1] 
0.061 
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Urea:creatinine - 
mmol/mmol 
Median [IQR] 
52  
[40, 99] 
93  
[68, 124] 
<0.001 
55  
[78, 102] 
79  
[63,92] 
<0.00
1 
51  
[44, 67] 
164  
[109, 200] 
<0.001 
44  
[36, 68] 
68  
[52, 113] 
<0.001 
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Figure S1:  Patient flow diagram for the London Trauma-ICU cohort. 
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Figure S2: Predictiveness of severity of illness at ICU admission or antecedent characteristics for 
hospital mortality for the entire trauma cohort. Shaded areas are 95% CIs. AUC - area under the curve. 
Total numbers of patients in still hospital on each day and number of these who subsequently dies are 
appended to the plot, of 1376 patients 25 were excluded for missing illness severity score at ICU 
admission. 
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Figure S3: Trajectories routinely measured metabolic and inflammatory parameters in 1135 major 
trauma ICU patients, surviving to day 10 without RRT. 436 patients with persistent critical illness (still 
in ICU at day 10 after admission) are compared to 699 without (patients initially admitted to ICU but 
discharged and still alive at day 10). Rolling medians with 95% confidence-intervals of the rolling 
estimate of the median value are shown using quadratic splines with the curve constrained to pass 
through the median admission value. 
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Figure S4: Trajectories of routinely measured metabolic and inflammatory parameters in 1135 major 
trauma ICU patients, surviving to day 10 without RRT stratified by ICU length of stay: <5 days (n=424), 
5-9 days (n=275), 10-19 days (n=277) and >20 days (n=159). Rolling medians with 95% confidence-
intervals of the rolling estimate of the median value are shown using quadratic splines with the curve 
constrained to pass through the median admission value.  
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Figure S5: Trajectories of serum creatinine, urea and urea:creatinine in all 1376 patients across the first 20 days of hospital admission by maximal AKI status 
or need for RRT. Rolling medians with 95% confidence-intervals of the point estimate of the median value using quadratic splines with the curve constrained 
to pass through the median admission value. 
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Figure S6: Discrimination of persistent need for intensive care from 1351 trauma-ICU patients (25 
patients without recorded admission APACHE II score excluded).  Patients in hospital with blood tests 
available on each day were considered.  For each day logistic regression models were constructed with 
persistent need for intensive care on that day as the dependent variable using as explanatory 
variables: model i) initial illness severity, age and comorbidity (New Injury Severity Score, APACHE 2, 
Age & Charlson Index) or model ii) urea:creatinine and haemoglobin concentration on that day (see 
table S1).  Model AUC (c-statistics) with 95% confidence intervals are plotted. Total numbers of 
patients with blood tests on each day and number of these still in ICU are appended. By day 10 
urea:creatinine and haemoglobin concentration discriminate persistent need for intensive care better 
than a combination of acute and chronic admission variables. Using Delong test for comparison of 
AUC, model ‘i’ (baseline characteristics) is superior to ‘ii’ (urea:creatinine and haemoglobin) on days 
2, 3 and 4 (p<0.05) while  model ‘ii’ was superior to model ‘i’ on days 11 to 25 (p<0.05).  
 ICU -  Intensive care unit; APACHE II - acute physiology and chronic health evaluation II, AUC - Area 
under curve. 
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Figure S7:  Discrimination of persistent need for intensive care from 1351 trauma-ICU patients (25 
patients without recorded admission APACHE 2 score excluded).  Patients in hospital with blood tests 
available on each day were considered.  For each day logistic regression models were constructed with 
persistent need for intensive care on that day as the dependent variable using as explanatory 
variables: i) initial illness severity, age and comorbidity (New Injury Severity Score, APACHE 2, Age & 
Charlson Index) or ii) daily values for routinely measured metabolic and inflammatory parameters 
examined in this study.  Model AUC (c-statistics) with 95% confidence intervals are plotted.   
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Figure S8. Correlation between L3 CSA and L4 psoas muscle cross-sectional areas 
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Figure S9. (A) Individual patients L3 muscle index (L3 cross-sectional area cm2 / m2 height) between 
admission and second computed tomography image. Blue and red dashed lines represent male and 
female sarcopaenia thresholds for males (<55.4 cm2/m2) and females (<38.9 cm2/m2) respectively 
[4]. (B) Individual patients L4 psoas muscle index (L4 psoas cross-sectional area/m2 height) between 
admission and second computed tomography image. 
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Figure S10: Corrleation between CT-assessed muscle cross-sectional area and urea:creatinine in 
muscle assessment patients with evolving, current or recent persistent critical illness at time of second 
CT and those who did not develop or had resolved persistent critical illness at time of second CT (see 
methods). Urea:creatinine was unrelated to muscle area at baseline however it was correlated with a 
lower muscle area in those with evolving, current or recent persistent critical illness. This assocition 
was not consistently seen in patients without or resolved persitent critical illness. Pearson R2 and 
associated p-values are shown with regression lines and 95% confidence intervals. 
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Analysis using the MIMIC-III dataset  
To assess the generalisability of results we analysed data from the MIMIC-III database which 
documents 53,423 distinct hospital admissions of adult patients (aged 16 years or above) admitted 
to critical care units at the Beth Israel Deaconess Medical Center, Boston, Massachusetts (a level 1 
trauma centre) between 2001 and 2012. (MIMIC-III, a freely accessible critical care database 
Johnson AEW, Pollard TJ, Shen L, Lehman L, Feng M, Ghassemi M, Moody B, Szolovits P, Celi LA, 
and Mark RG. Scientific Data (2016). DOI: 10.1038/sdata.2016.35).  
 
For each hospital admission, ICU and Hospital LoS, age, sex, hospital mortality and responsible clinical 
service to identify trauma patients. Daily serum creatinine, serum urea, serum albumin, haemoglobin 
concentration neutrophil count and lymphocyte count were extracted.  In this data extract due to the 
nature of the data retrieval where more than one value was available on a given day the mean of all 
values on that day was used. Urea:creatinine was also calculated on a daily basis.  As only a small 
minority of patients had daily CRP values, this parameter was not analysed. Similarly, only a proportion 
of patients had differential white cell count so total white cell count is reported as a surrogate of 
Neutrophil count.  Provision of RRT in the ICU was identified by current procedural terminology codes 
associated with dialysis (90934-91000) and presence of date time events for dialysis or CRRT 
procedures. The MIMIC-III dataset does not contain trauma severity scores. Simplified Acute 
Physiology Score II (SAPS-II) values were calculated from physiological and laboratory data within 
MIMIC-III from day of ICU admission. APACHE 2 scores are not currently available using this 
methodology.  
 
From MIMIC-III we extracted 3148 trauma-ICU admissions with one or more relevant blood tests 
during ICU admission; patients with unknown date of birth or ICU length of stay were excluded. We 
then excluded 29 patients with first creatinine >354 or who received RRT in ICU leaving 3119 
admissions for analysis.  Of these 432 (13.9%) had an ICU LoS of ≥10 days.  Compared to the London 
cohort these patients were older, had lower mortality, a higher proportion with ICU LoS of <10 days 
and shorter duration of both ICU and hospital length of stays in both groups (Table S4). As a measure 
of illness severity SAPS -2 scores were lower in patients with short ICU admissions in MIMIC-III 
compared to the London Cohort, 24 (IQR: 16-32) vs. 34.00 (IQR: 26-42), while SAPS-2 scores at 
admission in those who died and those that had ICU LoS of ≥10 days did not significantly differ 
between the cohorts. Overall these differences may reflect a lower threshold for ‘trauma-ICU’ 
admission in the US compared to the UK, where many lower acuity cases are admitted directly to a 
specialist trauma ward, and a differing demographic case-mix. MIMIC-III contains blood test results 
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from both during and after ICU admission, however as overall length of stay was shorter than in the 
London cohort, especially in the group with ICU LoS <10 days, trajectories are plotted over the first 14 
days from ICU admission to avoid selection bias at timepoints more distant from admission (Fig. 1c, 
Fig S11, Table S5). Similarly, trajectories of urea:creatinine stratified by length of stay were generated 
(Fig. 1d).  Finally, ability of urea:creatinine and haemoglobin to discriminate persistent need for 
intensive care on each day over the first 3 weeks in hospital was calculated in a similar fashion to that 
in our principal analysis (Fig. S12).  
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Figure S11: Patient flow diagram for the MIMIC-III trauma-ICU cohort (B) 
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Table S4: Characteristics of 3119 adult trauma-ICU admissions from the MIMIC III database 
 
 In ICU at day 10 
Discharged ICU 
& Alive at day 10 
P-value 
in ICU vs. 
discharged d10 
Died on or 
before day 10 
Number (% of total) 432 (13.9%) 2444 (78.4%)  243 (7.8%) 
Age - years  (median 
[IQR]) 
53 [34, 72] 48 [30, 68] 0.020 70 [45, 82] 
Sex = Male (% of 
category) 
299 (70.2%) 1611 (67.3%) 0.261 154 (63.3%) 
Died in Hospital (% of 
category) 
52 (12.2%) 24 (1.0%) <0.001 243 (100.0%) 
SAPS-2 Score at ICU 
admission (median 
[IQR]) 
34 [26-42] 24 [16-32] <0.001 43 [34-54] 
ICU LoS - days (median 
[IQR]) 
15 [12, 21] 2 [1,3] * 2 [1, 4] 
Trauma Hospital LoS - 
days (median [IQR]) 
22 [17,30] 6 [4, 11] * 2 [1,5] 
Total ICU bed-days (% 
of total) 
7677 (52.9%) 6100 (42.0%) * 738 (5.0%) 
Total Trauma Hospital 
bed-days (% of total) 
11 339(33.4%) 21 803(64.2%) * 802 (2.4%) 
 
* Comparisons not made as groups defined by length of stay 
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Table S5: Blood results adult trauma-ICU patients analysed from the MIMIC III database. Receiver-operating characteristic Area Under the Curves for 
discrimination of ICU status at day 10 with 95% confidence interval are shown.  
* Albumin values only available in 1218 cases.   **% Change calculated only from those with bloods on day 1 and day 10 
 In ICU at day 10 Discharged ICU& Alive at day 10 
ROC-AUC 
(95% CI) 
For ICU 
status at 
day 10 
 
Day 0 
Number 
with 
bloods 
Day 0 
Day 10 
Number 
with bloods 
Day 10 % change Day 
0 to Day 10** 
Day 0 
Number 
with bloods 
Day 0 Day 10 
Number 
with 
bloods 
Day 10 
% 
change 
Day 0 
to Day 
10** 
Creatinine (µmol/L) 
71 
[62-88] 
426 
62 
[53-80] 
396 
-17% 
[-30, 0] 
71 
[59-91] 
2393 
62 
[53-80] 
341 
-14% 
[-30, 
+5] 
0.50 
(0.46-0.54) 
Urea (mmol/L) 
4.6 
[3.3-6.4] 
426 
8.2 
[6.1-11.4] 
396 
+58% 
[+18, +118] 
5.2 
[3.8-7.0] 
2393 
5.7 
[4.3-8.9] 
341 
+15% 
[-13, 
+64] 
0.66 
(0.62-0.70) 
Urea:creatinine 
70 
[55-89] 
426 
127 
[101-168] 
396 
+89% 
[+44, +145] 
65 
[51-84] 
2393 
94 
[71-128] 
341 
+41% 
[+4%, 
+96%] 
0.70 
(0.66-0.74) 
Albumin (g/L)* 
30 
[25-35] 
125 
25 
[21-27] 
48 
-10% 
[-27, 3] 
35 
[31-39] 
428 
30 
[26-34] 
23 
-10% 
[-17, 
+9] 
0.71 
(0.58-0.85) 
Hemoglobin (g/dl) 
10.9 
[9.9-12.2] 
420 
9.5 
[8.7-10.4] 
387 
-13% 
[-22, -4] 
11.5 [10.2, 
12.9] 
2320 
9.9 
[9.1-10.9] 
346 
-9% 
[-18, 
+2] 
0.61 
(0.57-0.65) 
Leukocytes (x103/mm2) 11.6 
[8.8-14.7] 
422 
14.4 
[11.3-18.7] 
390 
+23% 
[-7, +73] 
11.0 
[8.8-13.7] 
2342 
12.8 
[10.1-17.7] 
347 +14% 
0.57 
(0.53-0.61) 
 25 
[-16, 
+46] 
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Figure S12:  Trajectories of routinely measured metabolic and inflammatory parameters in 2876 
trauma ICU patients from the MIMIC-III database, surviving to day 10. 432 patients with persistent 
critical illness (still in ICU at day 10 after admission) were compared to 2444 without (patients initially 
admitted to ICU but discharged and still alive at day 10). Rolling medians with 95% confidence-
intervals of the rolling estimate of the median value are shown using quadratic splines with the curve 
constrained to pass through the median day 0 value. CRP was not considered due to small number of 
measurements in the database, similarly as differential white cell count was not consistently reported 
total white cell count is displayed, finally any albumin results were only available in around 1218 
patients. 
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Fig S13: Discrimination of persistent need for intensive care from 3131 trauma-ICU patients in the 
MIMIC-III database (17 with no values for urea excluded).  Patients in hospital with blood tests results 
available on each day were considered.  For each day logistic regression models were constructed with 
persistent need for intensive care on that day as the dependent variable using i) initial illness severity 
and age (SAPS-II and Age) or ii) urea:creatinine ratio and haemoglobin concentration on that day as 
explanatory variables.  Model AUC (c-statistics) with 95% continence intervals are plotted. Total 
numbers of patients with blood tests on each day and number of these still in ICU are appended. 
Model ‘i’ is superior to ‘ii’ on days 2-8, and thereafter model ‘ii’ performs as well or better  (significantly 
better on day 11, 14,15,16 & 20 , Delong’s test, p<0.005).   
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